Description

Flomoxef Sodium

Flomoxef Sodium is a beta-lactam antibacterial active pharmaceutical ingredient used in regulated pharmaceutical development, analytical evaluation, and sterile dosage-form manufacturing programs. It is the sodium salt of Flomoxef and has the molecular formula C₁₅H₁₇F₂N₆NaO₇S₂, a molecular weight of approximately 518.5 g/mol, and CAS Registry Number 92823-03-5. Flomoxef Sodium is
• A sodium salt of the Oxacephem antibacterial compound Flomoxef
• Active pharmaceutical ingredient for qualified sterile drug-development programs
• Suitable for analytical method development, formulation research, process development, and controlled manufacturing
• Requires careful control of identity, potency, related substances, moisture, and microbiological quality
• Supplied with attention to batch consistency, traceability, and controlled handling
• Supported by technical documentation for supplier qualification and quality review
Flomoxef Sodium is a structurally complex beta-Lactam compound associated with the Oxacephem class of antibacterial agents. Its structure includes a sodium carboxylate form and multiple functional groups that require controlled manufacturing, analytical characterization, storage, and handling. PubChem identifies Flomoxef Sodium as the sodium salt of Flomoxef and lists Flumarin among its deposited synonyms.
The material may be evaluated in pharmaceutical programs involving sterile powder-for-injection development, analytical reference work, impurity profiling, method validation, stability studies, and process-development activities. Suitability for a specific parenteral formulation cannot be determined from the chemical name alone. Development teams must evaluate the individual grade, potency basis, water content, solid-state characteristics, reconstitution behavior, solution stability, particulate controls, sterility requirements, bacterial endotoxin limits, and compatibility with the proposed container-closure system.
For organizations looking to buy Flomoxef Sodium, supplier qualification should extend beyond price and immediate availability. A qualified Flomoxef Sodium supplier should provide an unambiguous chemical identity, current material specification, traceable batch information, assay or potency data, related-substance testing, residual solvent information, water-content limits, and appropriate microbiological documentation. Customers should also determine whether the material is intended for research, analytical, development, or qualified pharmaceutical manufacturing use before purchase.
CarboMer approaches Flomoxef Sodium sourcing with a regulation-first and manufacturing-centered perspective. Research and development teams benefit from a supplier capable of supporting material evaluation, analytical method development, reconstitution studies, formulation screening, and scale-up planning. Quality professionals require clearly defined acceptance criteria, traceable lot documentation, and appropriate change-control communication. Procurement teams need confidence that the selected material can be purchased consistently as demand progresses from laboratory quantities to validation or commercial requirements.
When customers purchase Flomoxef Sodium for sterile pharmaceutical development, the material specification should be reviewed against the intended route of administration, processing method, and destination-market requirements. Relevant parameters may include identity, assay or potency, related substances, water content, residual solvents, elemental impurities, appearance, solution clarity, color, pH, particulate matter, microbial limits, bacterial endotoxins, and sterility status where applicable. Not every supplied grade will be suitable for injectable manufacturing.
The material is supported by standard technical documentation, including a Certificate of Analysis, Safety Data Sheet, and related product information where applicable. Available analytical methods, impurity controls, microbiological specifications, storage requirements, retest periods, and regulatory support should be confirmed for the individual grade before ordering. Batch-to-batch consistency, traceability, and controlled handling remain central to dependable pharmaceutical sourcing.
Flomoxef Sodium should be handled by trained personnel using appropriate pharmaceutical or laboratory controls. The current Safety Data Sheet and product-specific storage instructions should be reviewed before receiving, sampling, weighing, transferring, or processing the material. Exposure to moisture, contamination, excessive heat, and other conditions that may affect beta-lactam stability should be minimized. Facilities should also evaluate appropriate segregation and containment procedures for antibacterial compounds.
The material is packaged in suitable containers selected to protect its quality from moisture, contamination, light, and environmental exposure during storage and transportation. Packaging formats, minimum order quantities, availability, and lead times may be discussed according to analytical, development, validation, and qualified manufacturing requirements.
As with all CarboMer products, customers receive responsive technical communication and documentation support intended to advance material qualification, formulation development, analytical evaluation, scale-up, and long-term supply planning.